查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1701670

全球快速流感诊断测试 (RIDT) 市场：产业分析、规模、份额、成长、趋势和预测（2025-2032 年）

Rapid Influenza Diagnostic Tests Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 242 Pages | 商品交期: 2-5个工作天内

价格
简介目录

主要发现

  • 快速流感诊断测试（RIDT）市场规模：9.82亿美元（2025年）
  • 预计市值：17.495亿美元（2032年）
  • 全球市场成长率：8.6%（2025年至2032年的复合年增长率）

快速流感诊断测试（RIDT）市场 - 报告范围

流感快速诊断测试（RIDT）市场包括旨在短时间内（通常在 30 分钟内）检测呼吸道检体中的流感病毒抗原的诊断工具。这些测试对于及时诊断和管理流感感染照护现场，特别是在季节性流行和大流行期间。免疫测量技术的进步、人们对早期发现疾病的认识不断提高以及全球健康威胁的增加，都对市场发展势头做出了重大贡献。

市场成长动力

全球 RIDT 市场的成长很大程度上是由于季节性和大流行性流感疫情的增加，这推动了对快速且准确的照护现场诊断的需求。政府和卫生当局加强了公共卫生行动和监测计划，更加重视早期发现以控制感染。此外，数位和分子诊断领域的技术创新，例如更敏感和特异性的RIDT 的开发，正在扩大临床应用的范围和可靠性。这些测试在居家医疗和远距医疗保健环境中的日益普及进一步加速了市场渗透。此外，全球老年人口的成长，使他们面临更高的严重流感併发症风险，也增加了对快速简便的诊断方法的需求。

市场限制

儘管需求强劲，RIDT 市场仍面临重大限制。主要的限制在于，与 RT-PCR 等实验室方法相比，传统快速检测的敏感度相对较低，这会导致假阴性，并对后续临床决策构成挑战。这种限制可能会削弱临床医生对测试结果的信心，尤其是在重症加护环境中。此外，由于流感病毒的突变导致检测性能的变化，因此对保持一致的诊断准确性提出了挑战。监管障碍和产品召回也会阻碍市场的发展，特别是对于那些寻求将创新诊断技术商业化的新参与企业而言。此外，在资源有限的环境中，成本限制和对早期检测益处缺乏认识可能会限制 RIDT 的采用。

市场机会

面对这些挑战，RIDT 市场提供了多个有利可图的成长机会。分子诊断的整合度日益提高，尤其是基于 NAAT 的快速测试，由于其高灵敏度和快速的周转时间，被定位为临床和临床前环境中的首选。远端医疗和分散医疗保健的扩展为家庭流感检测开闢了新的管道，并得到了易于使用的数位检测套组的支援。新兴经济体，尤其是亚太和拉丁美洲的新兴经济体，由于对医疗保健基础设施的投资不断增加和意识不断增强，提供了尚未开发的市场潜力。此外，诊断公司和公共卫生机构之间的策略联盟可能会促进创新并加速下一代 RIDT 的部署。对大流行病防范和感染疾病监测的投资也为市场扩张创造了肥沃的土壤。

本报告研究了全球快速流感诊断测试 (RIDT) 市场，并对市场动态进行了详细分析，包括成长动力、趋势、机会和挑战。

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 任务
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长前景
  • COVID-19影响分析
  • 预测因子－相关性和影响力

第三章 增值考虑

  • 产品采用分析
  • 疾病流行病学
  • 技术进步
  • 监管格局
  • 价值链分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

4. 全球快速流感诊断检验（RIDT）市场展望

  • 主要亮点
    • 市场规模及与前一年同期比较
    • 绝对的商机
  • 市场规模分析及预测
    • 市场规模表现分析（2019-2024）
    • 当前市场规模分析与预测（2025-2032）
  • 全球快速流感诊断测试（RIDT）市场展望（按产品类型）
    • 简介/主要发现
    • 按产品类型分類的市场规模表现与分析（2019-2024 年）
    • 按产品类型分類的当前市场规模分析和预测（2025-2032）
    • 按产品类型进行市场吸引力分析
  • 全球快速流感诊断测试（RIDT）市场展望：测试类型
    • 简介/主要发现
    • 按测试类型分類的市场规模绩效分析（2019-2024）
    • 按测试类型分類的当前市场规模分析和预测（2025-2032）
    • 市场吸引力分析：测试类型
  • 全球快速流感诊断测试（RIDT）市场展望（按检测类型）
    • 简介/主要发现
    • 按检测类型分類的市场规模绩效分析（2019-2024 年）
    • 按检测类型分類的当前市场规模分析和预测（2025-2032）
    • 市场吸引力分析：检测类型
  • 全球快速流感诊断测试（RIDT）市场展望：样本类型
    • 简介/主要发现
    • 市场规模绩效分析：依样本类型（2019-2024）
    • 按样本类型分類的当前市场规模分析和预测（2025-2032）
    • 市场吸引力分析：样本类型
  • 全球快速流感诊断测试（RIDT）市场展望：最终用户
    • 简介/主要发现
    • 按最终用户分類的市场规模绩效分析（2019-2024 年）
    • 目前市场规模分析及最终用户预测（2025-2032）
    • 市场吸引力分析：最终用户

5. 全球快速流感诊断测试（RIDT）市场展望（按地区）

  • 主要亮点
  • 市场规模绩效分析：按地区（2019-2024）
  • 目前市场规模分析及各地区预测（2025-2032）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：地区

6. 北美快速流感诊断检验（RIDT）市场展望

7. 欧洲快速流感诊断检验（RIDT）市场展望

8. 东亚快速流感诊断检验（RIDT）市场展望

9. 南亚和大洋洲快速流感诊断测试（RIDT）市场展望

10. 拉丁美洲快速流感诊断检验（RIDT）市场展望

11.中东和非洲快速流感诊断测试（RIDT）市场展望

第十二章竞争格局

  • 市场占有率分析（2025年）
  • 市场结构
    • 竞争强度图：按市场
    • 竞争仪錶板
  • 公司简介（详情－概述、财务状况、策略、最新发展）
    • QuidelOrtho Corporation
    • BD
    • Thermo Fisher Scientific Inc.
    • Abbott
    • F. Hoffmann-La Roche Ltd
    • DiaSorin SpA
    • Meridian Life Science, Inc.
    • SEKISUI Diagnostics
    • Virax Biolabs
    • ACCESS BIO
    • Princeton BioMeditech Corporation
    • LifeSign LLC.
    • McKesson Medical-Surgical Inc.
    • Pfizer Inc.
    • EBOS Healthcare
    • KANEKA CORPORATION
    • Siemens Healthcare Private Limited
    • Healgen
    • iHealth Labs Inc.
    • SG Diagnostics
    • Flowflex UK
    • 其他的

第十三章 附录

简介目录
Product Code: PMRREP31040

Persistence Market Research has recently released a comprehensive report on the global Rapid Influenza Diagnostic Tests (RIDTs) Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Rapid Influenza Diagnostic Tests Market Size (2025E): US$ 982.0 Mn
  • Projected Market Value (2032F): US$ 1,749.5 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.6%

Rapid Influenza Diagnostic Tests Market - Report Scope:

The Rapid Influenza Diagnostic Tests (RIDTs) market encompasses diagnostic tools designed to detect influenza viral antigens in respiratory specimens within a short time frame, often under 30 minutes. These tests are crucial in point-of-care settings for timely diagnosis and management of influenza infections, especially during seasonal outbreaks or pandemics. Technological advancements in immunoassays, growing awareness of early disease detection, and increasing global health threats have significantly contributed to the market's momentum.

Market Growth Drivers:

The growth of the global RIDTs market is largely driven by rising incidences of seasonal and pandemic influenza, which has increased the demand for rapid and accurate point-of-care diagnostics. Enhanced public health initiatives and surveillance programs by governments and healthcare agencies have amplified the focus on early detection to curb transmission. In addition, technological innovations in digital and molecular diagnostics, including the development of more sensitive and specific RIDTs, have broadened clinical applications and reliability. The growing adoption of these tests in home care settings and remote healthcare environments further accelerates their market penetration. Moreover, the global increase in geriatric populations, who are at higher risk of severe influenza complications, adds to the demand for faster and convenient diagnostics.

Market Restraints:

Despite strong demand, the RIDTs market faces notable constraints. A key limitation lies in the relatively lower sensitivity of some conventional rapid tests compared to laboratory-based methods such as RT-PCR, leading to false negatives and subsequent challenges in clinical decision-making. This limitation can hinder clinician confidence in test results, especially in critical care scenarios. Additionally, variability in test performance due to mutations in influenza viruses poses challenges to maintaining consistent diagnostic accuracy. Regulatory hurdles and product recalls can also impede market progress, particularly for new entrants aiming to commercialize innovative diagnostics. Moreover, in resource-limited settings, cost constraints and lack of awareness about the benefits of early testing can restrict the widespread adoption of RIDTs.

Market Opportunities:

Amidst these challenges, the RIDTs market presents several lucrative growth opportunities. The increasing integration of molecular diagnostics, particularly NAAT-based rapid tests, offers high sensitivity with reduced turnaround times, positioning them as a preferred alternative in clinical and non-clinical settings. Expansion of telemedicine and decentralized healthcare has opened new channels for home-based influenza testing, supported by user-friendly digital test kits. Emerging economies, particularly in Asia-Pacific and Latin America, offer untapped market potential due to rising healthcare infrastructure investments and growing awareness. Furthermore, strategic collaborations between diagnostic companies and public health organizations can foster innovation and accelerate deployment of next-generation RIDTs. The ongoing focus on pandemic preparedness and investments in infectious disease surveillance also create fertile ground for market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the global RIDTs market's growth?
  • Which regions and segments are witnessing the highest adoption of RIDTs?
  • How are technological advancements reshaping diagnostic accuracy and speed?
  • Who are the leading players in the RIDTs market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and market forecasts for the next decade?

Competitive Intelligence and Business Strategy:

Leading players in the global RIDTs market, such as QuidelOrtho Corporation, BD, Abbott, and Thermo Fisher Scientific Inc., are heavily investing in the development of advanced diagnostic platforms with improved sensitivity and faster result delivery. These companies are also focusing on expanding their geographic footprint through mergers, partnerships, and distribution agreements. Innovations such as multiplex assays capable of detecting both influenza A and B simultaneously, and digital diagnostics with smartphone connectivity, are key strategic areas. Other players, including DiaSorin S.p.A., Meridian Life Science, and Virax Biolabs, are enhancing their assay technologies and collaborating with health authorities to bolster public health preparedness. Strengthening presence in home care and remote diagnostics through user-friendly formats continues to be a central strategy for competitive differentiation.

Companies Covered in This Report:

  • QuidelOrtho Corporation
  • BD
  • Thermo Fisher Scientific Inc.
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • DiaSorin S.p.A.
  • Meridian Life Science, Inc.
  • SEKISUI Diagnostics
  • Virax Biolabs
  • ACCESS BIO
  • Princeton BioMeditech Corporation
  • LifeSign LLC.
  • McKesson Medical-Surgical Inc.
  • Pfizer Inc.

Rapid Influenza Diagnostic Tests Market Segmentation:

By Product Type:

  • Conventional
  • Digital

By Test Type:

  • Influenza A Test
  • Influenza B Test
  • Influenza A+B Test

By Assay Type:

  • Immunochromatographic Assays
  • Immunofluorescence Assays
  • Nucleic Acid Amplification Test (NAAT)

By Sample Type:

  • Throat Swab
  • Nasal Swab
  • Nasal Aspirate
  • Nasopharyngeal Swab
  • Nasopharyngeal Aspirate
  • Nasopharyngeal Wash

By End User:

  • Hospitals & Clinics
  • Diagnostic Centers & Laboratories
  • Nursing Homes
  • Home Care Settings
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Rapid Influenza Diagnostic Tests Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Technological Advancement
  • 3.4. Regulatory Landscape
  • 3.5. Value Chain Analysis
  • 3.6. Key Deals and Mergers
  • 3.7. PESTLE Analysis
  • 3.8. Porter's Five Force Analysis

4. Global Rapid Influenza Diagnostic Tests Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Rapid Influenza Diagnostic Tests Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) and Analysis, By Product Type, 2019-2024
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.3.3.1. Conventional
      • 4.3.3.2. Digital
    • 4.3.4. Market Attractiveness Analysis: Product Type
  • 4.4. Global Rapid Influenza Diagnostic Tests Market Outlook: Test Type
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Test Type, 2019-2024
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
      • 4.4.3.1. Influenza A Test
      • 4.4.3.2. Influenza B Test
      • 4.4.3.3. Influenza A+B Test
    • 4.4.4. Market Attractiveness Analysis: Test Type
  • 4.5. Global Rapid Influenza Diagnostic Tests Market Outlook: Assay Type
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Assay Type, 2019-2024
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
      • 4.5.3.1. Immunochromatographic Assays
      • 4.5.3.2. Immunofluorescence Assays
      • 4.5.3.3. Nucleic Acid Amplification Test (NAAT)
    • 4.5.4. Market Attractiveness Analysis: Assay Type
  • 4.6. Global Rapid Influenza Diagnostic Tests Market Outlook: Sample Type
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Mn) Analysis, By Sample Type, 2019-2024
    • 4.6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
      • 4.6.3.1. Throat Swab
      • 4.6.3.2. Nasal Swab
      • 4.6.3.3. Nasal Aspirate
      • 4.6.3.4. Nasopharyngeal Swab
      • 4.6.3.5. Nasopharyngeal Aspirate
      • 4.6.3.6. Nasopharyngeal Wash
    • 4.6.4. Market Attractiveness Analysis: Sample Type
  • 4.7. Global Rapid Influenza Diagnostic Tests Market Outlook: End User
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 4.7.3.1. Hospitals & Clinics
      • 4.7.3.2. Diagnostic Centers & Laboratories
      • 4.7.3.3. Nursing Homes
      • 4.7.3.4. Home Care Settings
      • 4.7.3.5. Others
    • 4.7.4. Market Attractiveness Analysis: End User

5. Global Rapid Influenza Diagnostic Tests Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Rapid Influenza Diagnostic Tests Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Product Type
    • 6.2.3. By Test Type
    • 6.2.4. By Assay Type
    • 6.2.5. By Sample Type
    • 6.2.6. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 6.4.1. Conventional
    • 6.4.2. Digital
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 6.5.1. Influenza A Test
    • 6.5.2. Influenza B Test
    • 6.5.3. Influenza A+B Test
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 6.6.1. Immunochromatographic Assays
    • 6.6.2. Immunofluorescence Assays
    • 6.6.3. Nucleic Acid Amplification Test (NAAT)
  • 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 6.7.1. Throat Swab
    • 6.7.2. Nasal Swab
    • 6.7.3. Nasal Aspirate
    • 6.7.4. Nasopharyngeal Swab
    • 6.7.5. Nasopharyngeal Aspirate
    • 6.7.6. Nasopharyngeal Wash
  • 6.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 6.8.1. Hospitals & Clinics
    • 6.8.2. Diagnostic Centers & Laboratories
    • 6.8.3. Nursing Homes
    • 6.8.4. Home Care Settings
    • 6.8.5. Others
  • 6.9. Market Attractiveness Analysis

7. Europe Rapid Influenza Diagnostic Tests Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Test Type
    • 7.2.4. By Assay Type
    • 7.2.5. By Sample Type
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.4.1. Conventional
    • 7.4.2. Digital
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 7.5.1. Influenza A Test
    • 7.5.2. Influenza B Test
    • 7.5.3. Influenza A+B Test
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 7.6.1. Immunochromatographic Assays
    • 7.6.2. Immunofluorescence Assays
    • 7.6.3. Nucleic Acid Amplification Test (NAAT)
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 7.7.1. Throat Swab
    • 7.7.2. Nasal Swab
    • 7.7.3. Nasal Aspirate
    • 7.7.4. Nasopharyngeal Swab
    • 7.7.5. Nasopharyngeal Aspirate
    • 7.7.6. Nasopharyngeal Wash
  • 7.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.8.1. Hospitals & Clinics
    • 7.8.2. Diagnostic Centers & Laboratories
    • 7.8.3. Nursing Homes
    • 7.8.4. Home Care Settings
    • 7.8.5. Others
  • 7.9. Market Attractiveness Analysis

8. East Asia Rapid Influenza Diagnostic Tests Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By Test Type
    • 8.2.4. By Assay Type
    • 8.2.5. By Sample Type
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.4.1. Conventional
    • 8.4.2. Digital
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 8.5.1. Influenza A Test
    • 8.5.2. Influenza B Test
    • 8.5.3. Influenza A+B Test
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 8.6.1. Immunochromatographic Assays
    • 8.6.2. Immunofluorescence Assays
    • 8.6.3. Nucleic Acid Amplification Test (NAAT)
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 8.7.1. Throat Swab
    • 8.7.2. Nasal Swab
    • 8.7.3. Nasal Aspirate
    • 8.7.4. Nasopharyngeal Swab
    • 8.7.5. Nasopharyngeal Aspirate
    • 8.7.6. Nasopharyngeal Wash
  • 8.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.8.1. Hospitals & Clinics
    • 8.8.2. Diagnostic Centers & Laboratories
    • 8.8.3. Nursing Homes
    • 8.8.4. Home Care Settings
    • 8.8.5. Others
  • 8.9. Market Attractiveness Analysis

9. South Asia & Oceania Rapid Influenza Diagnostic Tests Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By Test Type
    • 9.2.4. By Assay Type
    • 9.2.5. By Sample Type
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.4.1. Conventional
    • 9.4.2. Digital
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 9.5.1. Influenza A Test
    • 9.5.2. Influenza B Test
    • 9.5.3. Influenza A+B Test
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 9.6.1. Immunochromatographic Assays
    • 9.6.2. Immunofluorescence Assays
    • 9.6.3. Nucleic Acid Amplification Test (NAAT)
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 9.7.1. Throat Swab
    • 9.7.2. Nasal Swab
    • 9.7.3. Nasal Aspirate
    • 9.7.4. Nasopharyngeal Swab
    • 9.7.5. Nasopharyngeal Aspirate
    • 9.7.6. Nasopharyngeal Wash
  • 9.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.8.1. Hospitals & Clinics
    • 9.8.2. Diagnostic Centers & Laboratories
    • 9.8.3. Nursing Homes
    • 9.8.4. Home Care Settings
    • 9.8.5. Others
  • 9.9. Market Attractiveness Analysis

10. Latin America Rapid Influenza Diagnostic Tests Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Test Type
    • 10.2.4. By Assay Type
    • 10.2.5. By Sample Type
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.4.1. Conventional
    • 10.4.2. Digital
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 10.5.1. Influenza A Test
    • 10.5.2. Influenza B Test
    • 10.5.3. Influenza A+B Test
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 10.6.1. Immunochromatographic Assays
    • 10.6.2. Immunofluorescence Assays
    • 10.6.3. Nucleic Acid Amplification Test (NAAT)
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 10.7.1. Throat Swab
    • 10.7.2. Nasal Swab
    • 10.7.3. Nasal Aspirate
    • 10.7.4. Nasopharyngeal Swab
    • 10.7.5. Nasopharyngeal Aspirate
    • 10.7.6. Nasopharyngeal Wash
  • 10.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.8.1. Hospitals & Clinics
    • 10.8.2. Diagnostic Centers & Laboratories
    • 10.8.3. Nursing Homes
    • 10.8.4. Home Care Settings
    • 10.8.5. Others
  • 10.9. Market Attractiveness Analysis

11. Middle East & Africa Rapid Influenza Diagnostic Tests Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By Test Type
    • 11.2.4. By Assay Type
    • 11.2.5. By Sample Type
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.4.1. Conventional
    • 11.4.2. Digital
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 11.5.1. Influenza A Test
    • 11.5.2. Influenza B Test
    • 11.5.3. Influenza A+B Test
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 11.6.1. Immunochromatographic Assays
    • 11.6.2. Immunofluorescence Assays
    • 11.6.3. Nucleic Acid Amplification Test (NAAT)
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 11.7.1. Throat Swab
    • 11.7.2. Nasal Swab
    • 11.7.3. Nasal Aspirate
    • 11.7.4. Nasopharyngeal Swab
    • 11.7.5. Nasopharyngeal Aspirate
    • 11.7.6. Nasopharyngeal Wash
  • 11.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.8.1. Hospitals & Clinics
    • 11.8.2. Diagnostic Centers & Laboratories
    • 11.8.3. Nursing Homes
    • 11.8.4. Home Care Settings
    • 11.8.5. Others
  • 11.9. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping by Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. QuidelOrtho Corporation
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product Type
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. BD
    • 12.3.3. Thermo Fisher Scientific Inc.
    • 12.3.4. Abbott
    • 12.3.5. F. Hoffmann-La Roche Ltd
    • 12.3.6. DiaSorin S.p.A.
    • 12.3.7. Meridian Life Science, Inc.
    • 12.3.8. SEKISUI Diagnostics
    • 12.3.9. Virax Biolabs
    • 12.3.10. ACCESS BIO
    • 12.3.11. Princeton BioMeditech Corporation
    • 12.3.12. LifeSign LLC.
    • 12.3.13. McKesson Medical-Surgical Inc.
    • 12.3.14. Pfizer Inc.
    • 12.3.15. EBOS Healthcare
    • 12.3.16. KANEKA CORPORATION
    • 12.3.17. Siemens Healthcare Private Limited
    • 12.3.18. Healgen
    • 12.3.19. iHealth Labs Inc.
    • 12.3.20. SG Diagnostics
    • 12.3.21. Flowflex UK
    • 12.3.22. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations